Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world setting

Data on the association between chimeric antigen receptor (CAR)-T-cell kinetics and patient outcome in the nontrial setting are missing, mainly due to the lack of broadly available CAR-T-cell diagnostic quantification tools. We performed prospective quantification of axicabtagene ciloleucel (axi-cel...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Blood Adv
Glavni autori: Ayuk, Francis A., Berger, Carolina, Badbaran, Anita, Zabelina, Tatjana, Sonntag, Tanja, Riecken, Kristoffer, Geffken, Maria, Wichmann, Dominic, Frenzel, Christian, Thayssen, Guenther, Zeschke, Silke, Kröger, Nicolaus, Fehse, Boris
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2021
Teme:
Stimulus Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8238487/
https://ncbi.nlm.nih.gov/pubmed/34100900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003959
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items